Gholami Hasti, Chmiel John A, Burton Jeremy P, Maleki Vareki Saman
Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada.
Department of Microbiology and Immunology, Western University, London, ON N6A 3K7, Canada.
Cancers (Basel). 2023 Feb 18;15(4):1300. doi: 10.3390/cancers15041300.
Not all cancer patients who receive immunotherapy respond positively and emerging evidence suggests that the gut microbiota may be linked to treatment efficacy. Though mechanisms of microbial contributions to the immune response have been postulated, one likely function is the supply of basic co-factors to the host including selected vitamins. Bacteria, fungi, and plants can produce their own vitamins, whereas humans primarily obtain vitamins from exogenous sources, yet despite the significance of microbial-derived vitamins as crucial immune system modulators, the microbiota is an overlooked source of these nutrients in humans. Microbial-derived vitamins are often shared by gut bacteria, stabilizing bioenergetic pathways amongst microbial communities. Compositional changes in gut microbiota can affect metabolic pathways that alter immune function. Similarly, the immune system plays a pivotal role in maintaining the gut microbiota, which parenthetically affects vitamin biosynthesis. Here we elucidate the immune-interactive mechanisms underlying the effects of these microbially derived vitamins and how they can potentially enhance the activity of immunotherapies in cancer.
并非所有接受免疫疗法的癌症患者都会产生积极反应,新出现的证据表明,肠道微生物群可能与治疗效果有关。尽管已经推测出微生物对免疫反应的作用机制,但一个可能的功能是为宿主提供包括特定维生素在内的基本辅助因子。细菌、真菌和植物可以自行合成维生素,而人类主要从外源获取维生素,然而,尽管微生物衍生的维生素作为关键的免疫系统调节剂具有重要意义,但微生物群作为人类这些营养素的来源却被忽视了。微生物衍生的维生素通常由肠道细菌共享,稳定微生物群落之间的生物能量途径。肠道微生物群的组成变化会影响改变免疫功能的代谢途径。同样,免疫系统在维持肠道微生物群方面起着关键作用,而肠道微生物群又会影响维生素的生物合成。在这里,我们阐明了这些微生物衍生维生素作用背后的免疫相互作用机制,以及它们如何潜在地增强癌症免疫疗法的活性。